Rhein promotes TRAIL-induced apoptosis in bladder cancer cells by up-regulating DR5 expression

Aging (Albany NY). 2022 Aug 19;14(16):6642-6655. doi: 10.18632/aging.204236. Epub 2022 Aug 19.

Abstract

Tumor necrosis factor-related apoptosis-inducing ligand (TRAIL) combined with sensitizer is a potential method to reverse TRAIL-resistance in tumor cells. Rhein (RH) is a monomer extracted from Chinese herbs that has been reported to show anti-tumor effects in a variety of tumor cells, but the role of RH in TRAIL-induced anti-tumor effects in bladder cancer cells has not been reported. In this study, we found that the combined treatment of a non-toxic concentration of RH with TRAIL significantly inhibited the proliferation and induced apoptosis in both TRAIL sensitive and resistant bladder cancer cell lines. Furthermore, we found that RH promoted bladder cancer cell apoptosis by up-regulating DR5 expression. Our findings provide potential value in the clinical treatment of bladder cancer.

Keywords: DR5; Rhein; TRAIL; bladder cancer; drug resistance.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Anthraquinones
  • Apoptosis
  • Cell Line, Tumor
  • Humans
  • Receptors, TNF-Related Apoptosis-Inducing Ligand* / genetics
  • Receptors, TNF-Related Apoptosis-Inducing Ligand* / metabolism
  • TNF-Related Apoptosis-Inducing Ligand / metabolism
  • TNF-Related Apoptosis-Inducing Ligand / pharmacology
  • Urinary Bladder Neoplasms* / drug therapy

Substances

  • Anthraquinones
  • Receptors, TNF-Related Apoptosis-Inducing Ligand
  • TNF-Related Apoptosis-Inducing Ligand
  • rhein